Vistin Pharma ASA (FRA:VP4) Net Interest Margin (Bank Only) %


FRA:VP4 Vistin Pharma ASA FRA:VP4
80 GF Score
Price €1.79
GF Value €2.27
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Vistin Pharma ASA Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:VP4
80GF Score
Vistin Pharma ASA FRA:VP4
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vistin Pharma ASA (FRA:VP4) Overvalued in 2026?

Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued. The current stock price of €1.79 is trading 21.1% below its estimated GF Value™ of €2.27. GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.

Key valuation signals for FRA:VP4:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €2.27 vs. price of €1.79 (21.1% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the FRA:VP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vistin Pharma ASA Business Description

Address Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
80GF Score

Get the complete analysis for FRA:VP4

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.79
Price
€2.27
GF Value